GlassScriptPhysician profile
Dana C Mays
NPI 1831370154
$3,395.98
in general payments reported to CMS, 2019-2025
19 companies · $238 in 2025
The $238 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.49 · 2020: $11.97 · 2021: $90.75 · 2022: $1,070 · 2023: $843 · 2024: $1,102 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,182.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,202.33 | 2022-2025 | Biktarvy, Sunlenca, Epclusa |
| Viiv Healthcare Company | $998.96 | 2022-2025 | Dovato, Cabenuva, Rukobia |
| Merck Sharp & Dohme LLC | $246.11 | 2022-2025 | Pifeltro, Delstrigo, Dificid |
| Janssen Products, LP | $230.76 | 2022-2023 | Symtuza |
| Emd Serono, INC. | $217.18 | 2022-2024 | Serostim, Serostim |
| Janssen Biotech, INC. | $162.91 | 2022-2023 | Symtuza |
| Abbvie INC. | $48.44 | 2021-2025 | |
| Vanda Pharmaceuticals INC. | $44.11 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $37.50 | 2025 | Rexulti |
| Janssen Scientific Affairs, LLC | $28.81 | 2022 | |
| Xeris Pharmaceuticals, INC. | $28.22 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $25.41 | 2024 | Caplyta |
| Theratechnologies INC. | $24.66 | 2022 | |
| Abbott Laboratories | $22.83 | 2022 | |
| Lilly USA, LLC | $20.14 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $16.05 | 2024 | Wegovy |
| Pfizer INC. | $15.88 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.65 | 2019 | |
| Sanofi Pasteur INC. | $12.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Mays listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.